What is a suitable headline title for a publication about complications of hyperosmolar hyperglycemic state (HHS) in older adults with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Crafting a Publication Title for HHS Complications in Older Adults with Type 2 Diabetes

Your publication title should emphasize the high mortality risk and unique clinical presentation of hyperosmolar hyperglycemic state (HHS) in older adults, as this population faces substantially higher mortality rates and more severe complications compared to younger patients. 1

Recommended Title Structure

Core Elements to Include

  • Specify "Hyperosmolar Hyperglycemic State (HHS)" rather than generic "hyperglycemic crisis" to distinguish from diabetic ketoacidosis (DKA), as HHS has distinct pathophysiology and higher mortality rates 1

  • Emphasize the geriatric population explicitly, as older adults (≥65 years) with HHS have more than twice the mortality risk compared to younger patients and face unique complications including cognitive impairment, falls, and functional decline 1

  • Highlight specific complications such as cerebral edema, central pontine myelinolysis, thrombotic events, or mortality outcomes, as these represent the most clinically significant morbidity and mortality endpoints 1, 2, 3

Suggested Title Formats

Option 1 (Mortality-Focused): "Mortality and Neurological Complications of Hyperosmolar Hyperglycemic State in Older Adults with Type 2 Diabetes: A [Study Type] Analysis"

Option 2 (Complication-Specific): "Central Pontine Myelinolysis and Cerebral Edema in Elderly Patients with Hyperosmolar Hyperglycemic State: Risk Factors and Outcomes"

Option 3 (Population-Focused): "Hyperosmolar Hyperglycemic State in Geriatric Type 2 Diabetes: Complications, Mortality, and Management Challenges"

Critical Terminology Considerations

Use "Hyperosmolar Hyperglycemic State (HHS)" Not "Non-Ketotic"

  • The term "non-ketotic" is outdated and imprecise, as approximately 10% of HHS cases present with mixed DKA-HHS features with some ketonemia 1, 2

  • Modern diagnostic criteria define HHS by osmolality ≥320 mOsm/kg, glucose ≥30 mmol/L (≥540 mg/dL), pH >7.3, and bicarbonate ≥15 mmol/L, without requiring complete absence of ketones 2, 3

Specify "Older Adults" or "Geriatric" Rather Than Generic Terms

  • Older adults represent a clinically distinct population with higher baseline comorbidities, polypharmacy, cognitive impairment, and functional limitations that substantially increase HHS mortality 1

  • This population requires different treatment approaches, including more cautious fluid resuscitation (fluid losses 100-220 mL/kg must be replaced carefully to avoid fluid overload in elderly patients with cardiac/renal compromise) 1, 2

Complications to Emphasize Based on Clinical Impact

Highest Mortality/Morbidity Complications

Neurological complications carry the highest morbidity risk and should be prioritized in your title:

  • Central pontine myelinolysis occurs with rapid osmolality correction (>8 mOsm/kg/h decline) and causes permanent neurological damage 2, 3
  • Cerebral edema, though rare, is potentially fatal and more common in elderly patients 1, 4
  • Seizures occur in up to 25% of HHS cases and indicate severe osmotic disturbances 2, 5

Cardiovascular complications represent the leading cause of death:

  • Myocardial infarction and stroke are common precipitants and complications of HHS 2, 3
  • Thrombotic events including deep vein thrombosis and pulmonary embolism occur due to severe hyperosmolality and dehydration 2

Mortality rates are substantially higher in HHS than DKA:

  • Overall HHS mortality ranges from 10-20%, compared to <1% for DKA 2, 3
  • Elderly patients have even higher mortality, particularly those with euglycemic hyperosmolar hypernatremic state (a variant with glucose <600 mg/dL but osmolality >320 mOsm/kg), which carries 35% mortality 6

Common Pitfall to Avoid

Do not use "hyperosmolar non-ketotic coma" in your title, as this outdated term incorrectly implies all patients present in coma (only 25-50% have altered mental status severe enough to qualify as coma), and the "non-ketotic" designation is imprecise given mixed presentations 1, 2, 3

Additional Title Considerations

If Focusing on Management Complications

  • Emphasize iatrogenic complications from overly aggressive treatment, particularly rapid osmolality correction leading to central pontine myelinolysis (aim for 3-8 mOsm/kg/h decline) 2, 3

  • Highlight fluid overload complications in elderly patients with cardiac/renal disease who require careful monitoring during the 100-220 mL/kg fluid replacement 2

If Focusing on Diagnostic Challenges

  • Consider emphasizing the euglycemic hyperosmolar hypernatremic state variant, which has 35% mortality but may be missed due to glucose <600 mg/dL 6

  • Highlight mixed DKA-HHS presentations, which occur in approximately 10% of cases and require modified treatment approaches 1, 2

Geographic or Institutional Context

  • If your study involves specific healthcare settings (intensive care unit, emergency department, long-term care facilities), include this in the subtitle to clarify the clinical context 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of hyperosmolar hyperglycaemic state in adults with diabetes.

Diabetic medicine : a journal of the British Diabetic Association, 2015

Guideline

Management of Hyperglycemic Crisis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.